{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":11,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":11,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"fddd65d259ba","filters":{"venue":"Journal of Market Access & Health Policy"}},"results":[{"id":"W2999237747","doi":"10.1080/20016689.2020.1715536","title":"Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries","year":2020,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Reimbursement; Payment; European union; Business; Quarter (Canadian coin); Product (mathematics); Health care; European market; Medicine; Marketing; Finance; Economic growth; Economics; International trade; Geography","authors":[{"name":"Jesper Jørgensen","is_ca":false},{"name":"Eve Hanna","is_ca":false},{"name":"Panos Kefalas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0599014430613446,"gpt":0.4323923096100905,"spread":0.3724908665487459,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003910298,0.0001463922,0.0005076423,0.0002366939,0.00007672349,0.00003767314,0.0003182168,0.00008123994,0.00005482913],"category_scores_gemma":[0.0009057397,0.00008447942,0.0001115487,0.0004571955,0.0002688812,0.0001891138,0.00004592582,0.0004534147,3.832566e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002096385,"about_ca_system_score_gemma":0.001355307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008304585,"about_ca_topic_score_gemma":0.0001205096,"domain_scores_codex":[0.9971475,0.0006873342,0.001115667,0.0001465341,0.0006129877,0.0002899834],"domain_scores_gemma":[0.9973633,0.0007750699,0.001149565,0.0001794988,0.0003364404,0.0001960995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04530923,0.004619083,0.3197872,0.01112912,0.001100603,0.0003090386,0.3133869,0.0003980188,0.01013274,0.003850128,0.03618325,0.2537947],"study_design_scores_gemma":[0.01443271,0.002120349,0.6917568,0.0008822297,0.00009121653,0.00002599545,0.01002512,0.0008271438,0.001750625,0.0005343249,0.2773035,0.0002499049],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2167749,0.004645938,0.0004009095,0.7768118,0.0001710081,0.000782205,0.00001392037,0.000006844671,0.000392421],"genre_scores_gemma":[0.9497097,0.005193003,0.001299282,0.04333819,0.000366615,0.00001352551,0.00000374603,0.00002297612,0.00005295185],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7334737,"threshold_uncertainty_score":0.3444971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193864401","doi":"10.1080/20016689.2021.1964791","title":"Accelerating patient access to oncology medicines with multiple indications in Europe","year":2021,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Reimbursement; Market access; Business; Product (mathematics); Process (computing); Medicine; Actuarial science; Operations management; Computer science; Economics; Health care; Economic growth","authors":[{"name":"Ryan Lawlor","is_ca":false},{"name":"Tim Wilsdon","is_ca":false},{"name":"E. Darquennes","is_ca":false},{"name":"Dimitri Hemelsoet","is_ca":false},{"name":"J. Huismans","is_ca":false},{"name":"R.E. Normand","is_ca":true},{"name":"Alexander Roediger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5673573973348432,"gpt":0.5849998081847655,"spread":0.01764241084992224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0231322,0.0005377893,0.006499161,0.003867495,0.0002667091,0.0003963626,0.001735061,0.0003582812,0.0004312066],"category_scores_gemma":[0.02396383,0.0005083623,0.0002903531,0.003063517,0.00007256566,0.00126153,0.0004589435,0.001243016,0.00009225337],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004607846,"about_ca_system_score_gemma":0.01390805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003744734,"about_ca_topic_score_gemma":0.002685865,"domain_scores_codex":[0.9811201,0.003066691,0.01387084,0.000733081,0.0003073701,0.0009019389],"domain_scores_gemma":[0.9721886,0.004502201,0.02107144,0.0007367357,0.0005678986,0.0009331388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005934426,0.0005994579,0.009843135,0.02585139,0.0003834344,0.000070183,0.002871613,0.000136769,7.133348e-9,0.002834406,0.3031282,0.6542221],"study_design_scores_gemma":[0.0007391313,0.0004145414,0.00343684,0.01456872,0.00003416843,0.0001860901,0.0002171977,0.00004061636,2.720245e-8,0.0001288232,0.9798492,0.0003846065],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002024198,0.8562139,0.0003869477,0.1361906,0.0008428162,0.002123998,0.0002552348,0.00001661762,0.003767401],"genre_scores_gemma":[0.0001932021,0.9508461,0.002343392,0.0439877,0.002066832,0.0002681984,0.00005326228,0.0001130863,0.0001281948],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.676721,"threshold_uncertainty_score":0.9997368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4398182533","doi":"10.3390/jmahp12020009","title":"Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance","year":2024,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Protocol (science); Health technology; Critical appraisal; Medicine; Business; Political science; Alternative medicine; Health care","authors":[{"name":"K. Thokagevistk","is_ca":false},{"name":"Céline Coppo","is_ca":false},{"name":"L Rey","is_ca":false},{"name":"Amanda Carelli","is_ca":false},{"name":"Veronica Díez","is_ca":false},{"name":"Sarah Vaselenak","is_ca":true},{"name":"Liana Oliveira","is_ca":false},{"name":"Emilia Sicari","is_ca":false},{"name":"Teresa Ramos","is_ca":false},{"name":"Susanne Schach","is_ca":false},{"name":"Erika Schirghuber","is_ca":false},{"name":"Alex Simpson","is_ca":false},{"name":"Rémy Choquet","is_ca":false},{"name":"K Le Lay","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6991957781312884,"gpt":0.6739127582861535,"spread":0.02528301984513492,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1214745,0.0008547012,0.0105229,0.005505941,0.0002919594,0.0004114021,0.002608371,0.0004769042,0.0007579806],"category_scores_gemma":[0.09826343,0.0008911653,0.0007435553,0.004361656,0.0002777912,0.003038285,0.00105491,0.00224679,0.0002003849],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.009484454,"about_ca_system_score_gemma":0.01982137,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02247768,"about_ca_topic_score_gemma":0.005833488,"domain_scores_codex":[0.9531973,0.006538456,0.03612509,0.001856645,0.0007794506,0.001503081],"domain_scores_gemma":[0.9468861,0.02599161,0.02301784,0.001823846,0.0007543036,0.001526252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001196407,0.0002308129,0.001862715,0.3686634,0.0003781539,0.00001531569,0.0004709101,0.000002828899,2.274706e-8,0.02290592,0.3493209,0.2549526],"study_design_scores_gemma":[0.0009458637,0.0009093253,0.0008247416,0.4207599,0.0001200548,0.00001154876,0.00006058148,0.00003094217,2.44451e-8,0.001682552,0.5742393,0.0004152251],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002918166,0.6344922,0.000251837,0.3580988,0.001628434,0.004568671,0.0005902231,0.00002905123,0.0003116651],"genre_scores_gemma":[0.0001203052,0.9514667,0.00719199,0.03730579,0.002211109,0.0006562429,0.00001695865,0.0001093565,0.0009215364],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.320793,"threshold_uncertainty_score":0.9993539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2551027286","doi":"10.3402/jmahp.v4.33248","title":"A training paradigm to enhance performance and safe use of an innovative neuroendovascular device","year":2016,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; University of British Columbia","funders":"","keywords":"Computer science; Training (meteorology); Complement (music); Selection (genetic algorithm); Medical physics; Medicine; Artificial intelligence","authors":[{"name":"Donald R. Ricci","is_ca":true},{"name":"Thomas R. Marotta","is_ca":true},{"name":"Howard A. Riina","is_ca":false},{"name":"Martina Wan","is_ca":false},{"name":"Joost de Vries","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09066446744580157,"gpt":0.4091008253124968,"spread":0.3184363578666952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001343624,0.000187008,0.000726937,0.0004731507,0.00009190357,0.00003734199,0.0002515938,0.00004551899,0.00003431185],"category_scores_gemma":[0.001370187,0.0001214621,0.00009929579,0.0007818774,0.0001151167,0.001094422,0.0000598904,0.0002460642,0.000001052875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009180476,"about_ca_system_score_gemma":0.0008219464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001052676,"about_ca_topic_score_gemma":0.0000225031,"domain_scores_codex":[0.9975827,0.0003470499,0.001001476,0.0002294194,0.0004555836,0.0003837924],"domain_scores_gemma":[0.9976287,0.0004657432,0.0008240027,0.0003281168,0.0003005757,0.0004528903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001830681,0.0002070309,0.009712001,0.001001611,0.0002056308,0.00004936584,0.0022729,0.000005458051,0.001158795,0.0002261194,0.001723986,0.9816064],"study_design_scores_gemma":[0.001976351,0.002394066,0.9020899,0.002122287,0.00005801807,0.001078906,0.0000861699,0.00003988181,0.003450146,0.0001177321,0.08640106,0.0001854701],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9743389,0.000337853,0.0004332499,0.02405344,0.0001237629,0.0003536642,0.00001138781,0.00001088593,0.0003368665],"genre_scores_gemma":[0.9864908,0.001831132,0.00215503,0.009028346,0.0003539887,0.000007643524,5.950224e-7,0.00002390649,0.0001085946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9814209,"threshold_uncertainty_score":0.4953082,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2488011870","doi":"10.3402/jmahp.v4.31463","title":"Challenges in striving to simultaneously achieve multiple resource allocation goals: the pan-Canadian Oncology Drug Review (pCODR) example","year":2016,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University","funders":"","keywords":"CLARITY; Prioritization; Order (exchange); Plan (archaeology); Resource allocation; Health care; Resource (disambiguation); Cancer drugs; Perspective (graphical); Business; Management science; Process management; Computer science; Risk analysis (engineering); Public relations; Political science; Medicine; Drug; Economics; Pharmacology; Finance","authors":[{"name":"Heather McDonald","is_ca":true},{"name":"Cathy Charles","is_ca":true},{"name":"Laurie Elit","is_ca":true},{"name":"Amiram Gafni","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4646607408831695,"gpt":0.5042006085953252,"spread":0.03953986771215573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05866551,0.0002457932,0.001485336,0.001206152,0.0002634947,0.00008102287,0.001185091,0.0001469183,0.00023948],"category_scores_gemma":[0.02779458,0.0001988681,0.0001512336,0.0005329351,0.00005873843,0.0007065062,0.000125705,0.0004172426,0.0002086423],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005426099,"about_ca_system_score_gemma":0.003150047,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1258546,"about_ca_topic_score_gemma":0.2744414,"domain_scores_codex":[0.9897058,0.002627857,0.00611438,0.0004646953,0.0001935368,0.0008937112],"domain_scores_gemma":[0.9841813,0.008578214,0.005486479,0.0006999626,0.0002030173,0.0008510099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002014185,0.0002597821,0.02365385,0.003478373,0.0001304811,0.00001754451,0.009012676,0.0002796247,0.000001821889,0.01246363,0.5348989,0.4156019],"study_design_scores_gemma":[0.0008602258,0.0002041441,0.05056445,0.00265622,0.00000527202,0.00004862467,0.0006727126,0.0002006148,5.692593e-7,0.002615682,0.9419434,0.0002280613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.01333626,0.04568747,0.0003157862,0.9330868,0.0003583816,0.001380189,0.00009816056,0.00001394047,0.005723077],"genre_scores_gemma":[0.6896473,0.1410694,0.0007191687,0.1658584,0.001878689,0.0001155929,0.0000047146,0.00006778866,0.0006389579],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.7672283,"threshold_uncertainty_score":0.9983919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593404984","doi":"10.1080/20016689.2017.1283106","title":"Role of preliminary registry data in development of a clinical trial for an innovative device: a small but integral piece of a health policy initiative","year":2017,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical trial; Medical physics; Health care; Data collection; Medicine; Process management; Risk analysis (engineering); Computer science; Business; Political science","authors":[{"name":"Donald R. Ricci","is_ca":true},{"name":"Joost de Vries","is_ca":false},{"name":"Raphaël Blanc","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3481206429235412,"gpt":0.5495211997656897,"spread":0.2014005568421485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005212225,0.0002215031,0.00159449,0.000709621,0.0001989095,0.00002525117,0.001263535,0.0001460526,0.00001056044],"category_scores_gemma":[0.005534978,0.0001770351,0.0001510086,0.0004864576,0.0002469762,0.0004870479,0.0003418478,0.0005010816,2.398254e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003335793,"about_ca_system_score_gemma":0.01968852,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007587026,"about_ca_topic_score_gemma":0.001401643,"domain_scores_codex":[0.9944217,0.0005564612,0.003931889,0.0002961984,0.0003810876,0.000412663],"domain_scores_gemma":[0.9887244,0.0006538893,0.008141732,0.0009684173,0.001215718,0.0002958658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2148289,0.01077408,0.07060311,0.003658454,0.0008020983,0.00001824169,0.01057982,0.000001621479,0.0001677089,0.003760936,0.002650535,0.6821545],"study_design_scores_gemma":[0.04584923,0.01301519,0.9317657,0.002041255,0.00008200324,0.0001101066,0.001508004,0.0002261928,0.0002759717,0.001800693,0.003150873,0.000174788],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633992,0.0003433984,0.0002763177,0.03241747,0.0001247492,0.001807173,0.0002933581,0.000006030222,0.001332273],"genre_scores_gemma":[0.9864366,0.0003719135,0.01076439,0.001318848,0.0009074058,0.00004281878,0.0000802312,0.00002379609,0.00005400108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8611626,"threshold_uncertainty_score":0.9990215,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401858295","doi":"10.3390/jmahp12030017","title":"Patient Experience and Satisfaction with Orthopedic Services at a Community (Rural) Setting Hospital—How Is It Different from Urban Setting","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Patient satisfaction; Patient experience; Orthopedic surgery; Quality (philosophy); Health care; Work (physics); Medicine; Narrative; Nursing; Psychology","authors":[{"name":"Khalid Hasan","is_ca":false},{"name":"Shahin Kayum","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04485319696164643,"gpt":0.4313270351385387,"spread":0.3864738381768923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001333634,0.0004218203,0.0007242369,0.0005752828,0.002628279,0.0001804141,0.0003517168,0.0002437279,0.0004889503],"category_scores_gemma":[0.000275925,0.0003144011,0.0001101356,0.0005574115,0.0001057547,0.00153566,0.0005074689,0.002591027,0.000009892206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002292435,"about_ca_system_score_gemma":0.001195639,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04745057,"about_ca_topic_score_gemma":0.007335858,"domain_scores_codex":[0.9928213,0.003249421,0.001704618,0.0003459862,0.0009416207,0.0009370187],"domain_scores_gemma":[0.9937379,0.002134806,0.002385804,0.000482624,0.0004534606,0.0008053428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002063283,0.00002659076,0.8338437,0.002837812,0.00009207957,0.00001273758,0.09929029,0.000001658406,0.000009340799,0.00001172295,0.02600509,0.03766266],"study_design_scores_gemma":[0.0008015786,0.0006963981,0.9437267,0.007522694,0.00005074845,0.00004080495,0.03478169,0.0003570162,0.00001129178,0.0001533251,0.01157265,0.0002851022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9123039,0.002685047,0.00005366335,0.08188616,0.00150178,0.00101739,0.0002637884,0.00008918962,0.0001991229],"genre_scores_gemma":[0.9836605,0.002329489,0.0003071126,0.01229688,0.001032394,0.000111305,0.00002751762,0.00006947847,0.0001653066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.109883,"threshold_uncertainty_score":0.9999308,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412693204","doi":"10.3390/jmahp13030038","title":"Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments","year":2025,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Agencia Española de Medicamentos y Productos Sanitarios; National Institute for Health and Care Excellence","keywords":"Health technology; European union; Best practice; Process (computing); Political science; Health care; Medicine; Process management; Public relations; Business; Knowledge management; Computer science; International trade","authors":[{"name":"Anne-Pierre Pickaert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7195339884714608,"gpt":0.6773990463529387,"spread":0.04213494211852209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08331088,0.000759178,0.01091806,0.006741478,0.0003450866,0.0002464597,0.001608717,0.0008603556,0.000153789],"category_scores_gemma":[0.01161398,0.0008189453,0.001278672,0.001715399,0.0001191877,0.0007995446,0.0005397344,0.00191358,0.00004238451],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01229621,"about_ca_system_score_gemma":0.02620133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002506392,"about_ca_topic_score_gemma":0.0005957312,"domain_scores_codex":[0.9578865,0.004335999,0.03467524,0.001150621,0.0003665353,0.001585056],"domain_scores_gemma":[0.9510424,0.004229626,0.04248304,0.001084104,0.0003530315,0.0008078475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004272882,0.0009438739,0.001128531,0.09545174,0.0005090407,0.000004538183,0.0001109731,0.000009989843,6.642641e-10,0.03646244,0.235738,0.6295981],"study_design_scores_gemma":[0.001609433,0.00109386,0.0008234405,0.03127078,0.00004080717,0.00002100332,0.0002526925,0.0001004424,8.723821e-9,0.008790476,0.9555498,0.0004472156],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001279481,0.7642648,0.002563689,0.2241313,0.002533129,0.004482374,0.001020746,0.00002723917,0.0009638597],"genre_scores_gemma":[0.00003601854,0.9454492,0.006964753,0.04495975,0.001257974,0.0006845649,0.00008715191,0.000100004,0.0004606139],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7198119,"threshold_uncertainty_score":0.9994261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400974639","doi":"10.3390/jmahp12030014","title":"Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"Steno Diabetes Center Copenhagen; Bayer","keywords":"Canagliflozin; Medicine; Internal medicine; Type 2 diabetes; Confounding; Hazard ratio; Randomized controlled trial; Kidney disease; Diabetes mellitus; Confidence interval; Endocrinology","authors":[{"name":"David Z.I. Cherney","is_ca":true},{"name":"Kerstin Folkerts","is_ca":false},{"name":"Paul Mernagh","is_ca":false},{"name":"Mateusz Nikodem","is_ca":false},{"name":"Joerg Pawlitschko","is_ca":false},{"name":"Peter Rossing","is_ca":false},{"name":"Neil Hawkins","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03849699808939505,"gpt":0.3778843863415415,"spread":0.3393873882521464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003762159,0.0002014753,0.0008425454,0.0007867998,0.00003874381,0.00005147803,0.0001352872,0.00003579737,0.00007142936],"category_scores_gemma":[0.0001414849,0.0001434613,0.00006141816,0.0007533923,0.00006425234,0.0002388009,0.00007661082,0.000270629,0.000001787622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007331494,"about_ca_system_score_gemma":0.001843884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007912545,"about_ca_topic_score_gemma":0.0004717631,"domain_scores_codex":[0.9982849,0.0001537273,0.0006414863,0.0001820686,0.0003780954,0.0003597123],"domain_scores_gemma":[0.9984957,0.0002426976,0.0004180225,0.0001587379,0.0001263919,0.0005584242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01557128,0.002081484,0.8645515,0.005910473,0.002175681,0.00007612511,0.001800664,0.0001564441,0.000004643145,0.000136696,0.06209698,0.04543802],"study_design_scores_gemma":[0.01142413,0.003132956,0.9757545,0.002932729,0.0003944352,5.627646e-7,0.00004065207,0.0004875784,0.00001103443,0.00002390584,0.005679493,0.0001179941],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887472,0.00450288,0.000003278962,0.005071009,0.0002644784,0.0006787642,0.00003381091,0.00001635826,0.0006822174],"genre_scores_gemma":[0.9985334,0.0004855183,0.00008798445,0.0004944869,0.0001998495,0.000007504523,0.00004328266,0.00002208649,0.0001259478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.111203,"threshold_uncertainty_score":0.5850182,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2968568322","doi":"10.1080/20016689.2019.1650596","title":"Why “American Patients First” is likely to raise drug prices outside of the United States","year":2019,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Blueprint; Negotiation; Drug prices; Administration (probate law); International trade; Drug pricing; Food and drug administration; Political science; International economics; Business; Economics; Public economics; Law; Actuarial science; Management","authors":[{"name":"Monique Dabbous","is_ca":false},{"name":"Cyprien Milea","is_ca":false},{"name":"Steven Simoens","is_ca":false},{"name":"C. François","is_ca":false},{"name":"Claude Dussart","is_ca":false},{"name":"L Chachoua","is_ca":false},{"name":"Borislav Borissov","is_ca":false},{"name":"Mondher Toumi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07185893170955603,"gpt":0.4186940409292448,"spread":0.3468351092196887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003694537,0.000635298,0.003612022,0.002268505,0.000317807,0.000268336,0.002787729,0.0001923795,0.000162277],"category_scores_gemma":[0.003120347,0.0003905732,0.0008255758,0.004243365,0.0001619342,0.0008691645,0.001242615,0.0008968518,0.0000453064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006293973,"about_ca_system_score_gemma":0.001655074,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1901135,"about_ca_topic_score_gemma":0.0009085359,"domain_scores_codex":[0.9934071,0.000511527,0.003613529,0.0003928875,0.0007803584,0.001294581],"domain_scores_gemma":[0.9847219,0.001090328,0.01208649,0.000739402,0.001104395,0.0002574835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004307888,0.0000949258,0.001495577,0.02689334,0.0001074411,8.165772e-7,0.00009217468,0.00005406304,6.913786e-10,0.0001625167,0.8480093,0.1230467],"study_design_scores_gemma":[0.0003777082,0.00007698002,0.004161497,0.007101456,0.0001903905,0.000005366037,0.00006472647,0.0000531633,6.5311e-9,0.0001442314,0.9875319,0.0002925756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001504727,0.4552006,0.00002443485,0.5333653,0.002884634,0.002944448,0.0002576662,0.00004303032,0.003775187],"genre_scores_gemma":[0.00005205799,0.711757,0.00005022165,0.2856468,0.002212565,0.00001863051,0.00003450646,0.00006730021,0.0001609682],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2565564,"threshold_uncertainty_score":0.9998546,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402185636","doi":"10.3390/jmahp12030020","title":"Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Discontinuation; Atrial fibrillation; Medicine; Internal medicine; Cardiology","authors":[{"name":"M. Ingham","is_ca":false},{"name":"Hela Romdhani","is_ca":true},{"name":"Aarti A. Patel","is_ca":false},{"name":"Veronica Ashton","is_ca":false},{"name":"Gabrielle Caron‐Lapointe","is_ca":true},{"name":"Anabelle Tardif‐Samson","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04110476782569135,"gpt":0.4063531100015693,"spread":0.365248342175878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002368029,0.0002560975,0.0008926691,0.002272322,0.000128837,0.0002647156,0.0002105636,0.00009732559,0.0001143359],"category_scores_gemma":[0.0003002884,0.0001257859,0.0002706551,0.00372355,0.00004035734,0.0005610381,0.00003358753,0.0003552339,9.919448e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003156477,"about_ca_system_score_gemma":0.0008847663,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00663409,"about_ca_topic_score_gemma":0.002271449,"domain_scores_codex":[0.9965089,0.0004859704,0.001065049,0.000248222,0.001306968,0.0003849026],"domain_scores_gemma":[0.9978829,0.0006577196,0.0007635962,0.000225071,0.0002257621,0.0002449267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004560802,0.00002938487,0.9791213,0.000277458,0.0008115757,0.0001203584,0.0005314258,0.004733341,2.059257e-7,0.000001902331,0.0003530797,0.009459156],"study_design_scores_gemma":[0.005086762,0.0009721934,0.8933247,0.001175333,0.0009823273,0.00000716237,0.0001409624,0.09742306,0.000001412987,0.000004787288,0.0007491648,0.000132127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983076,0.00004297275,0.003792187,0.01198305,0.00009603921,0.0009114199,0.00001830696,0.00002680102,0.00005321737],"genre_scores_gemma":[0.9974235,0.0002409036,0.0001074196,0.0006881583,0.001203588,0.000001871349,0.000230021,0.00003267806,0.0000718515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09268972,"threshold_uncertainty_score":0.9999808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}